TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)
$9.8644 -0.1581 (-1.5775%)
Analysed TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) News Sources
Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing
16-07-2026
yahoo.com
Telix opens radiopharmaceutical facility in Australia for cancer treatment
16-07-2026
pharmaceutical-technology.com
Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study
16-07-2026
yahoo.com
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer
20-07-2026
yahoo.com
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
20-07-2026
yahoo.com
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
21-07-2026
yahoo.com
Does Telix Pharmaceuticals Limited (TLX) Have the Potential to Rally 86.17% as Wall Street Analysts Expect?
22-07-2026
yahoo.com
How Telix landed a $2.1 billion radiopharma deal with Regeneron
30-07-2026
pharmavoice.com
Why Regeneron (REGN) Is Up 6.7% After Mixed Q2 Results And New Telix Oncology Deal
30-07-2026
yahoo.com
Telix H1 2026 Results: Investor Webcast Notification
30-07-2026
yahoo.com
What is the current price of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)?
The current price of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) is $9.8644.
TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) since the previous trading day is $-0.1581.
TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) since the previous trading day is -1.5775%.
What is the most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)?
The most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) is 86 out of 100.
What is the most recent average sentiment for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)?
The most recent sentiment for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) is .
SEC-8K** Filing Available For TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.